{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:40:12Z","timestamp":1793144412688,"version":"4.5.0"},"reference-count":64,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Rosacea is a chronic inflammatory dermatosis characterized by vascular dysregulation, immune dysfunction, neurovascular alterations, and microbial involvement. Recent advances in understanding its pathophysiology have led to the development of targeted therapeutic strategies addressing multiple disease mechanisms. This systematic review aimed to evaluate contemporary evidence regarding emerging and established treatment approaches for rosacea. Methods: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, Scopus, and Web of Science were searched for studies published between 2016 and 2025. Original human studies evaluating therapeutic interventions for rosacea were included. Study selection, data extraction, and risk-of-bias assessment were performed independently by two reviewers. Methodological quality was assessed using Joanna Briggs Institute (JBI) critical appraisal tools appropriate for each study design. Results: Fifteen studies involving 537 patients with rosacea and 77 controls (614 participants in total) met the eligibility criteria. Evaluated interventions included vascular-targeted therapies, topical anti-inflammatory agents, systemic and immunomodulatory treatments, and microbiome-oriented approaches. Oxymetazoline, pulsed-dye laser, platelet-rich plasma, ivermectin, azelaic acid, dapsone, sulfur preparations, and metronidazole demonstrated clinical benefits in reducing erythema, inflammatory lesions, or overall disease severity. Emerging therapies, including tofacitinib and oral ivermectin, showed promising results in refractory disease. Microbiome-related interventions, particularly Demodex-targeted therapies and Helicobacter pylori eradication, were also associated with clinical improvement. Risk-of-bias assessment identified two studies with low risk of bias, twelve with moderate risk of bias, and one study with high risk of bias. Conclusions: Current evidence supports a multimodal and mechanism-based approach to rosacea management, integrating vascular, inflammatory, immunological, and microbiological targets. However, the available evidence remains limited by small sample sizes, heterogeneous methodologies, short follow-up periods, and a predominance of non-randomized study designs. Large, well-designed randomized controlled trials are needed to establish optimal evidence-based treatment strategies and define the long-term efficacy and safety of emerging therapies.<\/jats:p>","DOI":"10.3390\/ph19070982","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:41:38Z","timestamp":1782909698000},"page":"982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Latest Advances in Rosacea Treatment: A Systematic Review"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9331-7342","authenticated-orcid":false,"given":"Anastazja","family":"Andrusiewicz","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiia","family":"Khimuk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Ni\u017cnik","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Sirko","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mijas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1717-4280","authenticated-orcid":false,"given":"Danuta","family":"Nowicka","sequence":"additional","affiliation":[{"name":"University Centre of General Dermatology and Oncodermatology, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40257-020-00546-8","article-title":"Microbiota in Rosacea","volume":"21","author":"Kim","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard Management Options for Rosacea: The 2019 Update by the National Rosacea Society Expert Committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: New Concepts in Classification and Treatment","volume":"22","author":"Arents","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_4","first-page":"187","article-title":"Rosacea: Diagnosis and Treatment","volume":"92","author":"Muncie","year":"2015","journal-title":"Am. Fam. Physician"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/CCID.S390921","article-title":"A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State","volume":"15","author":"Yang","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdrv.2024.12.006","article-title":"Prevalence of Rosacea: A Systematic Review and Meta-Analysis of Population-Based Studies","volume":"3","author":"Geng","year":"2025","journal-title":"JAAD Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: Pathogenesis and Therapeutic Correlates","volume":"28","author":"Geng","year":"2024","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_8","first-page":"684","article-title":"Rosacea in Childhood and Adolescence: A Review","volume":"23","author":"Korsing","year":"2025","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent Advances in Understanding and Managing Rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Research"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, X., Shi, H., Li, X., and Feng, Y. (2025). Macrophages in Rosacea: Pathogenesis and Therapeutic Potential. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1595493"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yang, F., Wang, L., Song, D., Zhang, L., Wang, X., Du, D., and Jiang, X. (2024). Signaling Pathways and Targeted Therapy for Rosacea. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1367994"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17894","DOI":"10.1038\/s41598-025-02796-0","article-title":"Influence of Sodium Bituminosulfonate and Doxycycline on Signal Molecules Relevant for Rosacea Symptoms","volume":"15","author":"Rein","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1361574","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: Epidemiology, Pathogenesis, and Treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Derm.-Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/ddg.14849","article-title":"S2k Guideline: Rosacea","volume":"20","author":"Bernhard","year":"2022","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for Rosacea Diagnosis, Classification and Management: Update from the Global ROSacea COnsensus 2019 Panel","volume":"182","author":"Schaller","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/jocd.14816","article-title":"Rosacea Management: A Comprehensive Review","volume":"21","author":"Sharma","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1111\/jocd.15923","article-title":"A Systematic Review to Evaluate the Efficacy of Azelaic Acid in the Management of Acne, Rosacea, Melasma and Skin Aging","volume":"22","author":"King","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/CCID.S485237","article-title":"Azelaic Acid: Mechanisms of Action and Clinical Applications","volume":"17","author":"Feng","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.5114\/ada.2023.133955","article-title":"The Multiple Uses of Azelaic Acid in Dermatology: Mechanism of Action, Preparations, and Potential Therapeutic Applications","volume":"40","author":"Sauer","year":"2023","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/1346-8138.16254","article-title":"Metronidazole Gel (0.75%) in Japanese Patients with Rosacea: A Randomized, Vehicle-controlled, Phase 3 Study","volume":"49","author":"Miyachi","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2147\/CCID.S58920","article-title":"The Role of Brimonidine Tartrate Gel in the Treatment of Rosacea","volume":"8","author":"Jackson","year":"2015","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2147\/PPA.S115708","article-title":"Spotlight on Brimonidine Topical Gel 0.33% for Facial Erythema of Rosacea: Safety, Efficacy, and Patient Acceptability","volume":"11","author":"Anderson","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000537807","article-title":"Scalp Rosacea Treated with Topical Ivermectin","volume":"10","author":"Nasca","year":"2024","journal-title":"Ski. Appendage Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00461","DOI":"10.1016\/j.parepi.2025.e00461","article-title":"Efficacy of Topical Ivermectin in Controlling Human Demodex Infestation: Evidence from Systematic Review and Meta-Analysis","volume":"31","author":"Paichitrojjana","year":"2025","journal-title":"Parasite Epidemiol. Control"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e70402","DOI":"10.1111\/jocd.70402","article-title":"Sulfur and Its Derivatives in Dermatology: Insights Into Therapeutic Applications\u2014A Narrative Review","volume":"24","author":"Chen","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjd.17590","article-title":"Interventions for Rosacea Based on the Phenotype Approach: An Updated Systematic Review Including GRADE Assessments","volume":"181","author":"Fedorowicz","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s13555-023-01048-1","article-title":"Emerging Medical Therapies in Rosacea: A Narrative Review","volume":"13","author":"Choe","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2147\/DDDT.S427530","article-title":"Oral Isotretinoin and Its Uses in Dermatology: A Review","volume":"17","author":"Paichitrojjana","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_29","first-page":"e57085","article-title":"Efficacy of Low-Dose Isotretinoin in the Treatment of Rosacea: A Systematic Review and Meta-Analysis","volume":"16","author":"Assiri","year":"2024","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ddg.14247","article-title":"Evaluation of the Efficacy of Subantimicrobial Dose Doxycycline in Rosacea: A Systematic Review of Clinical Trials and Meta-Analysis","volume":"19","author":"Steinhoff","year":"2021","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tao, R.E., Prajapati, S., Pixley, J.N., Grada, A., and Feldman, S.R. (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. Antibiotics, 12.","DOI":"10.3390\/antibiotics12071152"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1869-5760-3-38","article-title":"Efficacy of Azithromycin 1.5% Eye Drops in Childhood Ocular Rosacea with Phlyctenular Blepharokeratoconjunctivitis","volume":"3","author":"Doan","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_33","first-page":"563709","article-title":"Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases","volume":"2012","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"159354","DOI":"10.1155\/2012\/159354","article-title":"Macrolides in Chronic Inflammatory Skin Disorders","volume":"2012","author":"Alzolibani","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00403-024-02895-4","article-title":"The Role of Vitamins and Nutrients in Rosacea","volume":"316","author":"Algarin","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_36","first-page":"544","article-title":"Treatment of Ocular Rosacea: Comparative Study of Topical Cyclosporine and Oral Doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","article-title":"Effects of Topical Retinoids on Acne and Post-Inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice","volume":"23","author":"Callender","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20406223251339964","DOI":"10.1177\/20406223251339964","article-title":"Rosacea and Treatment with Retinoids: A Systematic Review and Meta-Analysis","volume":"16","author":"Sticchi","year":"2025","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/ijmm.2024.5409","article-title":"Topical Calcineurin and Mammalian Target of Rapamycin Inhibitors in Inflammatory Dermatoses: Current Challenges and Nanotechnology-Based Prospects (Review)","volume":"54","author":"Sidiropoulou","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/pdia.2013.35619","article-title":"Topical Calcineurin Inhibitors in Dermatology. Part I: Properties, Method and Effectiveness of Drug Use","volume":"30","author":"Gutfreund","year":"2013","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3889\/oamjms.2019.783","article-title":"Botulin Toxin Use in Scars\/Keloids Treatment","volume":"7","author":"Scala","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3889\/oamjms.2019.784","article-title":"Botulin Toxin Use in Rosacea and Facial Flushing Treatment","volume":"7","author":"Scala","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cbi.2009.09.006","article-title":"Effect of Permethrin Insecticide on Rat Polymorphonuclear Neutrophils","volume":"182","author":"Gabbianelli","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s13555-020-00458-9","article-title":"The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?","volume":"10","author":"Forton","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_45","first-page":"e79295","article-title":"Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"17","author":"Alenezi","year":"2025","journal-title":"Cureus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000446215","article-title":"Rosacea Management","volume":"2","author":"Abokwidir","year":"2016","journal-title":"Ski. Appendage Disord."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2020.04.129","article-title":"Use of Beta-Blockers for Rosacea-Associated Facial Erythema and Flushing: A Systematic Review and Update on Proposed Mode of Action","volume":"83","author":"Logger","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mckenzie, J., Brennan, S., Ryan, R., Thomson, H., Johnston, R., and Thomas, J. (2019). Chapter 3: Defining the Criteria for Including Studies and How They Will Be Grouped for the Synthesis. Cochrane Handbook for Systematic Reviews of Interventions, Cochrane.","DOI":"10.1002\/9781119536604.ch3"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e16782","DOI":"10.1111\/jocd.16782","article-title":"Efficacy and Safety of Oxymetazoline 1% Cream for the Treatment of Mild to Moderate Facial Rosacea","volume":"24","author":"Sajdeh","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e15848","DOI":"10.1111\/dth.15848","article-title":"Tofacitinib for the Treatment of Erythematotelangiectatic and Papulopustular Rosacea: A Retrospective Case Series","volume":"35","author":"Sun","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/lsm.23176","article-title":"Treatment of Erythematotelangiectatic Rosacea with Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study","volume":"52","author":"Suggs","year":"2020","journal-title":"Lasers Surg. Med."},{"key":"ref_53","first-page":"6","article-title":"Treatment of Rosacea with Topical Ivermectin Cream: A Series of 34 Cases","volume":"22","year":"2016","journal-title":"Dermatol. Online J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e15049","DOI":"10.1111\/dth.15049","article-title":"Evaluation of the Efficacy and Safety of Platelet Rich Plasma Injection in Treatment of Rosacea","volume":"34","author":"Ghoz","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e14899","DOI":"10.1111\/dth.14899","article-title":"Rosacea with Persistent Facial Erythema and High Demodex Density Effectively Treated with Topical Ivermectin Alone or Combined with Oral Carvedilol","volume":"34","author":"Huang","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e14224","DOI":"10.1111\/dth.14224","article-title":"Clinical and Noninvasive Instrumental Evaluation of the Efficacy of a Nonsteroidal Anti-Inflammatory 8-Beta Glycyrrhetinic Acid Cream for the Treatment of Erythema in Rosacea","volume":"33","author":"Cameli","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jocd.12724","article-title":"The New Therapeutic Choice of Tranexamic Acid Solution in Treatment of Erythematotelangiectatic Rosacea","volume":"18","author":"Bageorgou","year":"2019","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/ejdv.ejdv_70_23","article-title":"Efficacy of Single-Dose Oral Ivermectin in Treatment of Rosacea in Relation to Demodex Mites","volume":"44","author":"Sharara","year":"2024","journal-title":"Egypt. J. Dermatol. Venerol."},{"key":"ref_59","first-page":"448","article-title":"Real-World Evidence for the Treatment of Rosacea with Sulfur or Metronidazole Preparation in Japanese Patients","volume":"6","author":"Nobeyama","year":"2023","journal-title":"JMA J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/abr.abr_236_22","article-title":"Association between the Treatment of Rosacea and Eradication of Helicobacter Pylori Infection","volume":"12","author":"Aghaei","year":"2023","journal-title":"Adv. Biomed. Res."},{"key":"ref_61","first-page":"e14920","article-title":"Erythema-Directed Digital Photography and Colorimeter Scores Correlate with Rosacea Erythema Evaluation in Patients under Treatment with Topical Ivermectin","volume":"34","author":"Lacarrubba","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jocd.14098","article-title":"A Novel Azelaic Acid Formulation for the Topical Treatment of Inflammatory Rosacea: A Multicentre, Prospective Clinical Trial","volume":"20","author":"Tedeschi","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e70212","DOI":"10.1111\/jocd.70212","article-title":"Comparison of Topical 20% Azelaic Acid and 7.5% Dapsone in the Treatment of Mild-To-Moderate Papulopustular Rosacea","volume":"24","author":"Hasanbeyzade","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_64","first-page":"e2024034","article-title":"Efficacy of Topical Dapsone 5% Gel for the Treatment of Erythematotelangiectatic Rosacea: New Treatment Option with Old Drug","volume":"14","year":"2024","journal-title":"Dermatol. Pract. Concept."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:20:27Z","timestamp":1783614027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ph19070982"],"URL":"https:\/\/doi.org\/10.3390\/ph19070982","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}